PharmaBoardroom

In a context where even well-established, multi-billion-dollar domestic companies have received warning letters from the US FDA, quality compliance…

The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology…

Much has been written on the potential for artificial intelligence (AI) to change the way in which healthcare is conducted around the world, from…

Carlos Mateos, founder and CEO of Spanish digital healthcare PR specialist, COM Salud, discusses opportunities for the healthcare sector in eHealth…

Filipe Paias, general manager for Baxter International Portugal, illustrates the organizational change Baxter has undergone in the past three years,…

Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and…

As the UK extracts itself from the European Union, key figures from the country's life sciences sector are split on the implications of Brexit for…

Secretary General João Goncalves of the Portuguese Trade Association for Medical Devices Companies (APORMED) – Portugal’s medtech association –…

Dr. Ángel Navarro, president of Azierta discusses how the company's strategy of linking science and business has created a consultancy space through…

Eduardo Lopez-Puertas, managing director of IFEMA, Spain’s largest and most successful congress center, discusses the country’s competitive…

Jose Manuel Rigueiro, general manager of the Spanish affiliate of Actelion, discusses the lack of trust between health authorities and the industry…

Nelson Pires provides an insightful update on Portugual’s pharmaceutical market evolution as well as Jaba Recordati’s ambitious Portuguese…